
Illumina, Inc.
NASDAQ:ILMN
85.6 (USD) • At close March 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Illumina, Inc. |
Symbool | ILMN |
Munteenheid | USD |
Prijs | 85.6 |
Beurswaarde | 13,559,040,000 |
Dividendpercentage | 0% |
52-weken bereik | 80.18 - 156.66 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Jacob Thaysen Ph.D. |
Website | https://www.illumina.com |
An error occurred while fetching data.
Over Illumina, Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)